Introduction
Endoscopic sphincterotomy (ES) is now the method of choice for removing common bile duct stones in most situations. First described 15 years ago,'2 ES, a therapeutic development of endoscopic retrograde cholangiopancreatography (ERCP) has replaced surgical exploration of the common bile ducts. Large series report the success rate and complications of ES. Formal trials, to evaluate the indications for and benefits of this technique, however, have only started to appear recently and some areas of its use remain controversial. This paper reviews the state of the art of ES in current clinical practice. There are few specific contraindications to endoscopic removal of common duct stones (Table I) . We shall discuss ES for stones causing duct obstruction, cholangitis and pancreatitis separately. The efficacy of sphincterotomy in patients with a gall bladder in situ remains controversial. Risk-benefit evaluation has to start with an assessment of complications.
Complications of endoscopic sphincterotomy
The major complications may be classified as early or late. Early complications include haemorrhage, cholangitis, pancreatitis and perforation. Haemor- rhage is usually self-limiting and rarely serious enough to require transfusion, provided there is no bleeding diathesis. In the largest series of endoscopic sphincterotomies reported in the UK3 the incidence of haemorrhage was 3.9% with transfusion required in 0.6%. It is probable that the size of sphincterotomy correlates with risk of haemorrhage although no data exist to support this hypothesis. Risks of cholangitis, pancreatitis and perforation were 1.6%, 0.9% and 0.5% respectively in the Middlesex Hospital series. 3 Retroperitoneal perforation generally heals spontaneously with conservative treatment. Overall mortality of ES is approximately 1.2%, but it is clear that in higher risk patients it may be greater. Thus, while sphincterotomy may be regarded as less interventional than surgery, it is not without significant morbidity and mortality.
The principle long term complications include stone recurrence and stenosis of the sphincterotomy. One study has assessed stenosis in detail. Rosseland and Solhaug4 measured sphincterotomy size prospectively in 68 of 75 patients with a gall bladder in situ. The mean diameter was 12.8 mm. In 11 patients there was a reduction of 20% in sphincterotomy diameter during a follow-up of up to 5 years but all patients were asymptomatic and In younger patients with a previous cholecystectomy, an endoscopic procedure is appropriate rather than surgical exploration on the basis of lower mortality and morbidity, albeit based on studies in older patients. [9] [10] [11] [12] The management of young, fit patients with a gall bladder in situ is as yet unclear with little published data to go on. Reported studies are retrospective reviews ofheterogeneous populations of patients -no randomized controlled trials have been described although they are under way. Can the existing published data give any guidelines? Table II summarizes the published data on a predominantly elderly population group and gives a brief meta-analysis.48 25 Procedural success is over 90% and common bile duct clearance approximately 72-100%. Complication rates are seen in about 10% of this group and mortality is variable. Clearly these patients -mainly elderly -would be at greater risk than younger patients whether ES or surgery is performed. Later cholecystectomy is needed in approximately 10% of patients indicating that successful clearance of the common duct alone is sufficient treatment for most patients. These data confirm the efficacy of ES alone in this predominantly elderly group. Despite all precautions some patients have retained duct stones after cholecystectomy. If a T-tube has been inserted in the bile duct, is of sufficient size (> 14 FG) and can be left long enough to form an adequate tract (greater than 4 weeks) then the percutaneous trans-T-tube tract approach can be used for stone removal. This technique has a lower complication rate than ES and is the method of choice. Often, however, the diameter of the T-tube inserted is too narrow to allow this approach and ES is indicated.
Acute pancreatitis
Gallstones are the most frequent (50%) underlying cause of acute pancreatitis in the UK. Mortality in this group is approximately 10% and it is hypothesized that the cause of the pancreatitis is gallstone impaction at the junction of the pancreatic and common bile ducts. Circumstantial support for this finding is provided by the fact that stones are found in the bile ducts in up to 60% ofpatients with pancreatitis but the incidence falls as the pancreatitis subsides. 30 However, it is not known whether the continued presence of gallstones is responsible for progression of an attack from mild to severe. Would all patients benefit from endoscopic decompression of the biliary tract or are there particular high risk groups?
Having confirmed the safety of sphincterotomy in 107 patients with gallstone pancreatitis3' Neoptolemos et al. reported a prospective randomized trial in 121 patients who received either sphincterotomy within 72 hours of admission or conventional resuscitative treatment only.32 They stratified patients within 48 hours ofadmission into mild or severe groups based on the modified Glasgow criteria33 and found that complications (particularly respiratory and heart failure, pseudocysts and pleural effusions), mortality and length of hospital stay were significantly lower in the group having ES. Moreover, there were no procedure-related complications in this group. It would therefore appear that early sphincterotomy may be the treatment ofchoice in severe gallstone pancreatitis. This represents approximately 25% of all admissions for pancreatitis.32 However, opinions differ as to exactly which patients should receive ERCP and ES since there is a high rate of spontaneous recovery.34
Failed endoscopic removal of common duct stones: options Failure to clear the common duct occurs in only 10% ofcases following successful ES. The principle reasons for failure of duct clearance will be that stones are too large (> 1.5 cm) or too numerous. The main adjuvant treatments available are lithotripsy, dissolution therapy and stenting.
Mechanical lithotripsy (stone crushing) has a role35 but is now being supplemented by extracorporeal shock wave techniques and lasers. Shock wave lithotripsy may be most appropriate for large stones36'37 with clearance rates of up to 86% and may become the treatment of choice where available. Pulsed laser lithotripsy also has potential using an endoscopically placed laser fibre.38 Comp- lications appear minimal to date but the potential for tissue damage requires a time consuming and sophisticated system to prevent tissue contact.
Dissolution therapy with methyltertbutyl ether, though successful,39 again requires technically demanding systems of delivery and its widespread application will be limited.
Endoprosthesis insertion is quick, usually easy and prevents subsequent duct obstruction and sepsis. Early studies demonstrating the feasibility of stents' have now been followed by larger studies4' which show successful drainage of the biliary tract in over 90% of cases with a 1 to 5 year follow-up.
Risk factor assessment in patients undergoing ES
With these expanding indications for ES, is there any way of identifying preprocedural risk factors which would help the (referring) clinician to choose the best approach for a particular patient?
Neoptolemos et al. 42 have shown that only serum bilirubin and albumin were of independent significance in predicting morbidity after ES. Medical conditions were not predictive of risk. Interestingly, they identified ES itself as a risk factor for complications after surgery. This group advocates further non-surgical procedures when possible, rather than operation, if there are ESrelated complications.
In elderly patients with gall bladders in situ there is a risk of cholecystitis and empyema after ES for duct stones. Davidson et al. 8 reported that the only factor predicting complications was the presence of pre-existing cholangitis. This emphasizes the requirement for complete clearance of duct stones as discussed above. Furthermore, non-filling of the gall bladder at cholangiography, implying an obstructed cystic duct, is associated with persistent symptoms and raised mortality.23 However, patient numbers are small in this study and are not supported by other, larger series.8
Conclusion
Endoscopic removal of common bile duct stones is now a routine procedure available in many district general hospitals as well as teaching centres. In general, it is the procedure of choice to remove common duct stones in the elderly and those with cholangitis. ERCP and ES is probably appropriate in patients with severe pancreatitis, particularly when not resolving. Retrospective analysis, however, reveals areas of considerable uncertainty, for example, its use in younger patients with intact gall bladders. Therapeutic ERCP carries with it complications and further effort is needed to precisely define risk factors for ES. Prospective studies of stone number and size, sphincterotomy diameter, non filling gall bladder, pre-existing cholangitis and laboratory criteria are difficult, but are needed to improve the management and outcome of patients with common bile duct stones.
